van Ommen GJ - Search Results

1

The Pathogenesis and Therapy of Muscular Dystrophies.

Guiraud S, Aartsma-Rus A, Vieira NM, Davies KE, van Ommen GJ, Kunkel LM. Guiraud S, et al. Among authors: van ommen gj. Annu Rev Genomics Hum Genet. 2015;16:281-308. doi: 10.1146/annurev-genom-090314-025003. Epub 2015 Jun 4. Annu Rev Genomics Hum Genet. 2015. PMID: 26048046 Review.

2

Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense.

Aartsma-Rus A, Janson AA, Kaman WE, Bremmer-Bout M, van Ommen GJ, den Dunnen JT, van Deutekom JC. Aartsma-Rus A, et al. Among authors: van ommen gj, van deutekom jc. Am J Hum Genet. 2004 Jan;74(1):83-92. doi: 10.1086/381039. Epub 2003 Dec 16. Am J Hum Genet. 2004. PMID: 14681829 Free PMC article.

3

Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy.

Goyenvalle A, Babbs A, van Ommen GJ, Garcia L, Davies KE. Goyenvalle A, et al. Among authors: van ommen gj. Mol Ther. 2009 Jul;17(7):1234-40. doi: 10.1038/mt.2009.113. Epub 2009 May 19. Mol Ther. 2009. PMID: 19455105 Free PMC article.

4

Progress in therapeutic antisense applications for neuromuscular disorders.

Aartsma-Rus A, van Ommen GJ. Aartsma-Rus A, et al. Among authors: van ommen gj. Eur J Hum Genet. 2010 Feb;18(2):146-53. doi: 10.1038/ejhg.2009.160. Epub 2009 Oct 7. Eur J Hum Genet. 2010. PMID: 19809477 Free PMC article. Review.

5

New insights in gene-derived therapy: the example of Duchenne muscular dystrophy.

Aartsma-Rus A, den Dunnen JT, van Ommen GJ. Aartsma-Rus A, et al. Among authors: van ommen gj. Ann N Y Acad Sci. 2010 Dec;1214:199-212. doi: 10.1111/j.1749-6632.2010.05836.x. Epub 2010 Dec 1. Ann N Y Acad Sci. 2010. PMID: 21121926 Review.

6

Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy.

Aartsma-Rus A, Bremmer-Bout M, Janson AA, den Dunnen JT, van Ommen GJ, van Deutekom JC. Aartsma-Rus A, et al. Among authors: van ommen gj, van deutekom jc. Neuromuscul Disord. 2002 Oct;12 Suppl 1:S71-7. doi: 10.1016/s0960-8966(02)00086-x. Neuromuscul Disord. 2002. PMID: 12206800

7

Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients.

Aartsma-Rus A, Janson AA, Kaman WE, Bremmer-Bout M, den Dunnen JT, Baas F, van Ommen GJ, van Deutekom JC. Aartsma-Rus A, et al. Among authors: van ommen gj, van deutekom jc. Hum Mol Genet. 2003 Apr 15;12(8):907-14. doi: 10.1093/hmg/ddg100. Hum Mol Genet. 2003. PMID: 12668614

8

Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.

Aartsma-Rus A, Janson AA, van Ommen GJ, van Deutekom JC. Aartsma-Rus A, et al. Among authors: van ommen gj, van deutekom jc. BMC Med Genet. 2007 Jul 5;8:43. doi: 10.1186/1471-2350-8-43. BMC Med Genet. 2007. PMID: 17612397 Free PMC article.

9

Less is more: therapeutic exon skipping for Duchenne muscular dystrophy.

Aartsma-Rus A, van Ommen GJ. Aartsma-Rus A, et al. Among authors: van ommen gj. Lancet Neurol. 2009 Oct;8(10):873-5. doi: 10.1016/S1474-4422(09)70229-7. Epub 2009 Aug 25. Lancet Neurol. 2009. PMID: 19713153 No abstract available.

10

Prednisolone treatment does not interfere with 2'-O-methyl phosphorothioate antisense-mediated exon skipping in Duchenne muscular dystrophy.

Verhaart IE, Heemskerk H, Karnaoukh TG, Kolfschoten IG, Vroon A, van Ommen GJ, van Deutekom JC, Aartsma-Rus A. Verhaart IE, et al. Among authors: van ommen gj, van deutekom jc. Hum Gene Ther. 2012 Mar;23(3):262-73. doi: 10.1089/hum.2011.127. Epub 2012 Jan 26. Hum Gene Ther. 2012. PMID: 22017442 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

410 results

Search Page

Filters